Web Desc
The Gut Microbiome: The Effector/Regulatory Immune Network
Organizer(s): Lloyd H. Kasper, Javier Ochoa-Repáraz and Sarkis K. Mazmanian
Date: February 10 - 15, 2013
Location: Sagebrush Inn & Suites, Taos, NM, USA
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Summary of Meeting:
The mammalian GI track harbors a complex assemblage of microbial organisms that are essential for the development of the immune system. Alterations of the gut microbiota may lead to immune dysregulation both in the gut and in distal effector sites leading to the development of autoimmune disease. This meeting will focus on the role of the microbiota in balancing the effector and regulatory response leading to immune homeostasis. Recent findings suggest that altering certain bacterial populations present in the gut can lead to an inflammatory state associated with Th1/Th17 polarization. In contrast, other commensal bacteria and their antigenic products, when presented in the correct context, are regulatory and protect against inflammation. Particular emphasis will be placed on the biologic dynamics of the microbiota, the interaction with APC, modulation of the regulatory network and the immunologic consequences on experimental and human autoimmune conditions such as IBD, CNS demyelination and RA. The practical application of these novel interactions between the host and gut microbiota may lead to the identification of new therapeutics and novel insights into the mechanisms of human autoimmunity. The opportunity to assemble basic scientists in bacteriology and mucosal immunology with clinicians to explore this rapidly expanding arena is unique as there have been no previous organized meetings to meet this need. How the gut microbiome guides effector and regulatory immune functions will provide new pathways for the development of novel therapeutic targets.
Scholarship Deadline: October 9 2012
Discounted Abstract Deadline: October 9 2012
Abstract Deadline: November 8 2012
Discounted Registration Deadline: December 5 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Boehringer Ingelheim Pharmaceuticals, Inc.
We gratefully acknowledge additional support for this conference from:
CrohnCubist Pharmaceuticals, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
The Journal of Rheumatology
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK084688-04
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, February 10 | 4:00PM - 8:00PM
Arrival and Registration
Room: Chamisa Lobby


Monday, February 11 | 7:00AM - 8:00AM
Breakfast
Room: Los Vaqueros


Monday, February 11 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Chamisa Ballroom 1

Speaker 1 of 2
* Lloyd H. Kasper, Geisel School of Medicine at Dartmouth, USA

Monday, February 11 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Chamisa Ballroom 1

Speaker 2 of 2
Dan R. Littman, HHMI/New York University School of Medicine, USA
The Gut Commensal Microbiota's Effects on Systemic Autoimmunity

Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 1 of 6
* Sarkis K. Mazmanian, California Institute of Technology, USA

Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 2 of 6
David A. Relman, Stanford University, USA
Assembly, Stability and Resilience of the Human Microbiome

Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 3 of 6
Javier Ochoa-Repáraz, Eastern Washington University, USA
The Gut as a Source of Therapeutic Molecules Against Autoimmune Diseases

Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 4 of 6
Gianfranco Grompone, BIOASTER, France
Short Talk: A Crypt Specific Core Microbiota Resides in the Mouse Colon

Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 5 of 6
Elaine Y. Hsiao, University of California, Los Angeles, USA
Short Talk: A Commensal Bacterium of the Gut Microbiome Modulates Serum Metabolites
and Ameliorates Behavioral Abnormalities in a Mouse Model of an Autism Risk Factor


Monday, February 11 | 9:00AM - 11:45AM
The Gut Microbiome
Room: Chamisa Ballroom 1

Speaker 6 of 6
Duane R. Wesemann, Harvard Medical School, USA
Short Talk: Development and Education of Early B Lineage Cells in the Gut Lamina Propria

Monday, February 11 | 9:40AM - 10:00AM
Coffee Break
Room: Chamisa Lobby


Monday, February 11 | 11:45AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Monday, February 11 | 11:45AM - 4:30PM
On Own for Lunch and Recreation


Monday, February 11 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Monday, February 11 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 1 of 6
* Dennis L. Kasper, Harvard Medical School, USA

Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 2 of 6
Chyi-Song Hsieh, Washington University, USA
Education of the Immune System by Commensal Microbiota

Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 3 of 6
Cathryn R. Nagler, University of Chicago, USA
Commensal Bacteria Induced Tregs and IgA Protect Against Allergic Responses to Food

Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 4 of 6
Makoto Kinoshita, Osaka University, Japan
Short Talk: Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon

Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 5 of 6
Katherine Nutsch, Washington University in St. Louis, USA
Short Talk: Commensal Microbiota-Specific TCRs Regulate Differentiation to a Regulatory Phenotype in an Inflammatory Environment

Monday, February 11 | 5:00PM - 7:00PM
Gut Microbiome and Immune Development
Room: Chamisa Ballroom 1

Speaker 6 of 6
Koji Atarashi, Research Center for Allergy & Immunology, RIKEN, Japan
Short Talk: Human Clostridium Species Promote Intestinal Accumulation of Treg Cells

Monday, February 11 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2


Monday, February 11 | 7:30PM - 10:00PM
Poster Session 1
Room: Chamisa Ballroom 2


Tuesday, February 12 | 7:00AM - 8:00AM
Breakfast
Room: Los Vaqueros


Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 1 of 6
* Dan R. Littman, HHMI/New York University School of Medicine, USA

Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 2 of 6
Nadine Cerf-Bensussan, Université Paris Descartes, France
Interactions of Segmented Filamentous Bacterium with the Host Immune System: Lessons from Gnotobiotic Mice

Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 3 of 6
Sarkis K. Mazmanian, California Institute of Technology, USA
A Microbial System Promotes Stable Colonization by Bacteroides of the Gut Microbiota

Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 4 of 6
Brian L. Kelsall, NIAID, National Institutes of Health, USA
Definition and Function of Mononuclear Phagocytes in the Colon

Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 5 of 6
Gérard Eberl, Institut Pasteur, France
Development and Regulation of Intestinal Innate Lymphoid Cells

Tuesday, February 12 | 8:00AM - 11:00AM
Gut Microbiome-Innate Cell Interactions
Room: Chamisa Ballroom 1
To appreciate the interaction between the gut microbiome and antigen presention such as dendritic cells, immunocytes that lead to the development or regulation of autoimmunity.
Speaker 6 of 6
Amiran Dzutsev, NCI, National Institutes of Health, USA
Short Talk: CD103+ Migratory Dendritic Cells Scout the Colon Luminal Space, Take Up Bacteria and Transport them to Colonic Lymphoid Patches

Tuesday, February 12 | 9:20AM - 9:40AM
Coffee Break
Room: Chamisa Lobby


Tuesday, February 12 | 11:00AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Tuesday, February 12 | 11:00AM - 4:30PM
On Own for Lunch and Recreation


Tuesday, February 12 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Tuesday, February 12 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 1 of 6
* Brian L. Kelsall, NIAID, National Institutes of Health, USA

Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 2 of 6
Richard S. Blumberg, Brigham and Women's Hospital, USA
CD1-NKT interactions in mucosal immunity

Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 3 of 6
Dennis L. Kasper, Harvard Medical School, USA
Sphingolipids of Commensals Modulate Host Immunity through Regulation of iNKT Cells

Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 4 of 6
David Artis, Weill Cornell Medical College, USA
Host-Microbial Interactions in Health and Disease

Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 5 of 6
Dingding An, Harvard Medical School, USA
Short Talk: Symbiotic Bacterial Sphingolipids Modulate Host Adaptive Immune System and Host Resistance to Experimental Colitis Challenge

Tuesday, February 12 | 5:00PM - 7:15PM
Experimental Colitis/IBD: Regulatory Networks
Room: Chamisa Ballroom 1
This session will focus on the role of the microbiome in the development or regulation of both human and experiemental inflammatory bowel disease.
Speaker 6 of 6
Suzanne Devkota, Cedars-Sinai Medical Center, USA
Short Talk: Omega-3 Supplementation Prevents Intestinal Inflammation by Inhibiting the Expansion of an Intestinal Pathobiont in IL10-/- Mice

Tuesday, February 12 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2


Tuesday, February 12 | 7:30PM - 10:00PM
Poster Session 2
Room: Chamisa Ballroom 2


Wednesday, February 13 | 7:00AM - 8:00AM
Breakfast
Room: Los Vaqueros


Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 1 of 7
* Javier Ochoa-Repáraz, Eastern Washington University, USA

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 2 of 7
Eric G. Pamer, University of Chicago, USA
Microbiota-Mediated Resistance to Infection by Intestinal Pathogens

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 3 of 7
Susan V. Lynch, University of California, San Francisco, USA
Gastrointestinal Microbiome and Pediatric Asthma Development

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 4 of 7
Gabriel Nuñez, University of Michigan, USA
Control of Pathogen Colonization and Eradication by Virulence Factors and the Gut Microbiota

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 5 of 7
Fiona M. Powrie, University of Oxford, UK
IL-23-Driven Cellular and Molecular Pathways that Promote Intestinal Inflammation and Colon Cancer

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 6 of 7
Nobuhiko Kamada, University of Michigan, USA
Short Talk: Controlling Virulence Factor Expression and Pathogen Eradication by Host Adaptive Immunity and the Gut Microbiota

Wednesday, February 13 | 8:00AM - 11:15AM
Gut Bacteria Modulation of Effector Networks
Room: Chamisa Ballroom 1
The objective of this session is to evaluate the interaction of the gut microbiome and its capacity to polarize the immune response to either an effector or regulatory phenotype.
Speaker 7 of 7
Gregory F. Sonnenberg, Weill Cornell Medicine, USA
Short Talk: Innate Lymphoid Cell Regulation of Host-Microbiota Interactions and Intestinal Homeostasis

Wednesday, February 13 | 9:20AM - 9:40AM
Coffee Break
Room: Chamisa Lobby


Wednesday, February 13 | 11:15AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Wednesday, February 13 | 11:15AM - 4:30PM
On Own for Lunch and Recreation


Wednesday, February 13 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Wednesday, February 13 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 1 of 6
* Richard S. Blumberg, Brigham and Women's Hospital, USA

Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 2 of 6
Gurumoorthy Krishnamoorthy, Max Planck Institute of Neurobiology, Germany
Commensal Microbiota as a Trigger of Spontaneous Autoimmune Demyelination

Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 3 of 6
Yun Kyung Lee, California Institute of Technology, USA
The Microbiota Impacts Vitamin D Status and Experimental Autoimmune Encephalomyelitis

Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 4 of 6
Lloyd H. Kasper, Geisel School of Medicine at Dartmouth, USA
Role of Commensal Bacteria in the Regulation of Central Nervous System Disease Demyelination

Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 5 of 6
Sin-Hyeog Im, POSTECH, South Korea
Short Talk: Immunomodulation of Neural Autoimmune Disorders with Probiotics

Wednesday, February 13 | 5:00PM - 7:00PM
Gut Modulation of Effector/Regulatory Networks in CNS Diseas
e

Room: Chamisa Ballroom 1

Speaker 6 of 6
Howard L. Weiner, Brigham and Women’s Hospital, Harvard Medical School, USA
Short Talk: Investigation of the Gut Microbiome in Multiple Sclerosis Patients

Wednesday, February 13 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2


Wednesday, February 13 | 7:30PM - 10:00PM
Poster Session 3
Room: Chamisa Ballroom 2


Thursday, February 14 | 7:00AM - 8:00AM
Breakfast
Room: Los Vaqueros


Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 1 of 8
* Lloyd H. Kasper, Geisel School of Medicine at Dartmouth, USA

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 2 of 8
Peter J. Turnbaugh, University of California, San Francisco, USA
An Active Subset of the Gut Microbiome Responsive to Xenobiotics

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 3 of 8
Curtis Huttenhower, Harvard School of Public Health, USA
From Microbial Surveys to Mechanisms of Interaction in the Gut Microbiome

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 4 of 8
Paul D. Cotter, Teagasc Food Research Centre, Ireland
Modulation of the Gut Microbiota; Impact of Antimicrobial Administration, Diet and other Factors

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 5 of 8
Fei Sjöberg, University of Gothenburg, Sweden
Short Talk: The Oral Microbiota in Infancy and its Relation to Allergy Development

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 6 of 8
Taylor J. Feehley, University of Chicago, USA
Short Talk: Oral Tolerance to Dietary Antigen Relies on TLR-Mediated Signals from the Enteric Microbiota

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 7 of 8
Georg K. Gerber, Harvard Medical School, USA
Short Talk: Principled Probabilistic Machine Learning Models for Analyzing Microbiome Time-Series Data

Thursday, February 14 | 8:00AM - 11:15AM
Modulation of Gut Microbiota
Room: Chamisa Ballroom 1

Speaker 8 of 8
Joël Doré, INRA / MetaGenoPolis, France
Short Talk

Thursday, February 14 | 9:20AM - 9:40AM
Coffee Break
Room: Chamisa Lobby


Thursday, February 14 | 10:00AM - 10:00AM
On Own for Lunch and Recreation


Thursday, February 14 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 1 of 7
* Javier Ochoa-Repáraz, Eastern Washington University, USA

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 2 of 7
Dennis Sandris Nielsen, University of Copenhagen, Denmark
The Role of Gut Microbiota in Diabetes Type I and II Development

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 3 of 7
Alexander V. Chervonsky, University of Chicago, USA
Glycosylation of Gut Epithelial Surfaces in Response to Systemic Infections

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 4 of 7
Christophe Benoist, Harvard Medical School, USA
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cell

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 5 of 7
Ivan Vujkovic-Cvijin, NIAID, National Institutes of Health, USA
Short Talk: Dysregulation of the Colonic Mucosally-Adherent Microbiota Is Associated with Inflammatory Markers of HIV Disease Progression

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 6 of 7
Mark Bazett, Qu Biologics Inc., Canada
Short Talk: The Intestinal Microbiome and Intestinal Disease in a deltaF508 Cystic Fibrosis Mouse Model

Thursday, February 14 | 5:00PM - 7:15PM
Gut Bacteria Modulation of Autoimmunity
Room: Chamisa Ballroom 1
This is a continuation of the morning session regarding the interaction of the gut microbiome with other autoimmune conditions.
Speaker 7 of 7
Sarkis K. Mazmanian, California Institute of Technology, USA
Closing Remarks

Thursday, February 14 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2


Thursday, February 14 | 8:00PM - 11:00PM
Entertainment
Room: Chamisa Ballroom 2


Thursday, February 14 | 8:00PM - 11:00PM
Cash Bar
Room: Chamisa Ballroom 2


Friday, February 15 | 10:25AM - 10:25AM
Departure


*Session Chair.